The thyroid hormone receptors as tumor suppressors

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Thyroid hormone receptors (TRs) regulate fundamental physiological processes.
• Emerging evidence implicates TRs in controlling cell proliferation and malignant transformation.
• The ras oncogene's role in cancer highlights the importance of its regulatory pathways.

Purpose of the Study:

• To investigate the role of TRs in inhibiting cancer cell proliferation and malignant transformation.
• To elucidate the mechanisms by which TRs affect tumor growth, invasion, and metastasis.
• To explore the therapeutic potential of TRs in cancer treatment.

Main Methods:

• Assessing the impact of TRs on cyclin D1 transcription induced by the ras oncogene.
• Evaluating tumor formation and progression in Ras-transformed fibroblasts and cancer cell lines in vivo.
• Analyzing the effects of TR expression and host thyroid status on tumor cell behavior and metastasis.
• Examining skin tumor malignancy in mice lacking TRs.

Main Results:

• TRs repress ras-induced cyclin D1 and inhibit Ras-transformed cell tumorigenesis.
• Mutant TRs lacking coactivator binding retain inhibitory functions, while those lacking corepressor binding do not.
• TRβ1 expression in cancer cells suppresses anchorage-independent growth, migration, and prometastatic gene expression, reducing tumor growth and metastasis.
• Hypothyroid host environment enhances tumor invasiveness and metastasis, independent of tumor cell TR expression.
• Mice lacking TRs exhibit increased skin tumor malignancy.

Conclusions:

• TRs act as potent inhibitors of cancer cell proliferation, invasion, and metastasis.
• The functional status of TRs (coactivator vs. corepressor binding) dictates their anti-cancer effects.
• Host thyroid hormone status significantly influences tumor progression and metastatic potential.
• TRs represent a promising therapeutic target for various cancers.